{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:32:37Z","timestamp":1761316357151,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tobacco Control Fund","award":["326.5-2\/60"],"award-info":[{"award-number":["326.5-2\/60"]}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["32003B_214832\/1"],"award-info":[{"award-number":["32003B_214832\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Res Involv Engagem"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Switzerland has taken a different path to cannabis regulation than other countries. A 2021 law allows regulatory experiments on the production and sale of cannabis for non-medical purposes. The research team planned a randomised controlled trial (RCT) to test how selling cannabis in pharmacies affects users\u2019 health and consumption habits. The study intervention also included counselling on risk reduction, such as smoking cessation. The research team aimed to incorporate the perspectives of people who use cannabis into the study design, despite challenges related to stigma and legal constraints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>When planning the RCT, the research team mandated an external researcher to form an advisory group with regular users of non-medical cannabis. This researcher used convenience sampling (including snowball sampling) to recruit people who use cannabis, considering age, self-reported gender and cannabis use frequency. She conducted an individual interview, followed by iterative group discussions. She summarised the results into reports and sent them to the research group, who considered the results during study planning and formulated topics to be discussed in the next advisory group meeting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In a two- and half-year long process (November 2021 to March 2024), eight people who use cannabis provided iterative feedback that informed the development of the study intervention. Based on their feedback, the research team expanded the product selection to include cannabis resin alongside cannabis flowers. The group\u2019s feedback also led the research team to make several changes to the sales process in pharmacies. While the members of the advisory group expressed that much of their feedback had been considered, they noted that some key aspects \u2014 such as product pricing \u2014 had not been implemented. Legal and political constraints limited the research team\u2019s ability to implement advisory group feedback.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This experience showed that gathering user input is feasible, even in highly regulated, stigmatized contexts. Including the perspectives of people who use cannabis in the trial set-up allowed the research team to adapt the study intervention. Where they could not adapt the study intervention, it helped them prepare for possible reactions from future study participants and disseminate their findings to other stakeholders. Future research should test the feasibility and benefits of such activities throughout all research stages.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40900-025-00791-3","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:26:35Z","timestamp":1761315995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Consulting people who use cannabis to plan a regulatory trial on non-medical cannabis sales in pharmacies"],"prefix":"10.1186","volume":"11","author":[{"given":"Anna Irina","family":"Schibli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"H.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"N.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"S.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Bieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Selby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Anne","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reto","family":"Auer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Metry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"791_CR1","unstructured":"Agency EEUD. Cannabis laws in Europe: questions and answers for policymaking 2023 [Available from: https:\/\/www.euda.europa.eu\/publications\/faq\/cannabis-laws-europe-questions-and-answers-for-policymaking_en]."},{"issue":"11","key":"791_CR2","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1177\/10497323231221674","volume":"34","author":"B Scholz","year":"2024","unstructured":"Scholz B, Kirk L, Warner T, O\u2019Brien L, Kecskes Z, Mitchell I. From a single voice to diversity: reframing \u2018Representation\u2019 in patient engagement. Qual Health Res. 2024;34(11):1007\u201318.","journal-title":"Qual Health Res"},{"key":"791_CR3","unstructured":"(NIHR) NIfHaCR. Public involvement in research: briefing notes for researchers [Internet] London: National Institute for Health and Care Research (NIHR); 2021 [updated May 2024; cited 2025 Jan 23]. Available from: https:\/\/www.nihr.ac.uk\/briefing-notes-researchers-public-involvement-nhs-health-and-social-care-research#tab-256881"},{"key":"791_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2018.01.016","volume":"55","author":"A Ritter","year":"2018","unstructured":"Ritter A, Lancaster K, Diprose R. Improving drug policy: the potential of broader Democratic participation. Int J Drug Policy. 2018;55:1\u20137.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"791_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1369-7625.2012.00795.x","volume":"17","author":"J Brett","year":"2014","unstructured":"Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review. Health Expect. 2014;17(5):637\u201350.","journal-title":"Health Expect"},{"key":"791_CR6","unstructured":"Staley K. Exploring impact: public involvement in nhs, public health and social care research 2009."},{"key":"791_CR7","unstructured":"Bundesgesetz \u00fcber die Bet\u00e4ubungsmittel und die psychotropen Stoffe (Bet\u00e4ubungsmittelgesetz, BetmG), Art. 8a. 2020."},{"key":"791_CR8","unstructured":"Federal Office of Public Health (FOPH) The four-pillar policy [Internet]. [cited 2025 Aug 20] Available from: https:\/\/www.bag.admin.ch\/en\/the-four-pillar-policy"},{"key":"791_CR9","unstructured":"Cook T. Where participatory approaches Meet pragmatism in funded (Health) research: the challenge of finding meaningful spaces. Forum Qualitative Sozialforschung. 2012;13."},{"issue":"3","key":"791_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1332\/174426419X15532579188099","volume":"15","author":"G Bammer","year":"2019","unstructured":"Bammer G. Key issues in co-creation with stakeholders when research problems are complex. Evid Policy. 2019;15(3):423\u201335.","journal-title":"Evid Policy"},{"key":"791_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugpo.2017.12.018","volume":"54","author":"V Belackova","year":"2018","unstructured":"Belackova V, Wilkins C. Consumer agency in cannabis supply - Exploring auto-regulatory documents of the cannabis social clubs in Spain. Int J Drug Policy. 2018;54:26\u201334.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"791_CR12","doi-asserted-by":"publisher","first-page":"e004943","DOI":"10.1136\/bmjopen-2014-004943","volume":"4","author":"D Snape","year":"2014","unstructured":"Snape D, Kirkham J, Britten N, Froggatt K, Gradinger F, Lobban F, et al. Exploring perceived barriers, drivers, impacts and the need for evaluation of public involvement in health and social care research: a modified Delphi study. BMJ Open. 2014;4(6):e004943.","journal-title":"BMJ Open"},{"issue":"1","key":"791_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12954-024-00929-8","volume":"21","author":"DD King","year":"2024","unstructured":"King DD, Gill CJ, Cadieux CS, Singh N. The role of stigma in cannabis use disclosure: an exploratory study. Harm Reduct J. 2024;21(1):21.","journal-title":"Harm Reduct J"},{"issue":"1","key":"791_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12916-019-1317-6","volume":"17","author":"J Millum","year":"2019","unstructured":"Millum J, Campbell M, Luna F, Malekzadeh A, Karim QA. Ethical challenges in global health-related stigma research. BMC Med. 2019;17(1):84.","journal-title":"BMC Med"},{"key":"791_CR15","unstructured":"Federal Office of Public Health (FOPH) FAQs on cannabis pilot trials [Internet]. 2024 [cited 2025 Aug 20]. Available from: https:\/\/www.bag.admin.ch\/en\/faqs-on-cannabis-pilot-trials"},{"key":"791_CR16","doi-asserted-by":"publisher","first-page":"104623","DOI":"10.1016\/j.drugpo.2024.104623","volume":"134","author":"SR Sznitman","year":"2024","unstructured":"Sznitman SR, Auer R, Havinga JC, Casalini A, Broers B. Social forces shaping evidence production: a study of the Swiss cannabis pilot trials. Int J Drug Policy. 2024;134:104623.","journal-title":"Int J Drug Policy"},{"key":"791_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40900-018-0102-6","volume":"4","author":"N Doria","year":"2018","unstructured":"Doria N, Condran B, Boulos L, Curtis Maillet DG, Dowling L, Levy A. Sharpening the focus: differentiating between focus groups for patient engagement vs. qualitative research. Res Involv Engagem. 2018;4:19.","journal-title":"Res Involv Engagem"},{"key":"791_CR18","unstructured":"Mavrot C, Hadorn S, Novet B. Analysis of results from cannabis pilot trials in Swiss Cities \u2014 Part I, 2023 to Mid-2024. 2024."},{"issue":"1","key":"791_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40900-021-00283-0","volume":"7","author":"K Selby","year":"2021","unstructured":"Selby K, Cardinaux R, Metry B, de Rougemont S, Chabloz J, Meier-Herrmann V, et al. Citizen advisory groups for the creation and improvement of decision aids: experience from two Swiss centers for primary care. Res Involv Engagem. 2021;7(1):37.","journal-title":"Res Involv Engagem"},{"key":"791_CR20","doi-asserted-by":"crossref","unstructured":"Miles S, Rowe G. The laddering technique. In: Breakwell GM, editor. Doing social psychology research. Volume 1. BPS Blackwell; 2004.","DOI":"10.1002\/9780470776278.ch13"},{"key":"791_CR21","unstructured":"Mayring P. Qualitative content analysis. Forum Qualitative Sozialforschung. 2000;1."},{"key":"791_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40900-017-0062-2","volume":"3","author":"S Staniszewska","year":"2017","unstructured":"Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. Res Involv Engagem. 2017;3:13.","journal-title":"Res Involv Engagem"},{"key":"791_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40900-015-0008-5","volume":"1","author":"K Staley","year":"2015","unstructured":"Staley K. Is it worth doing?\u2019 measuring the impact of patient and public involvement in research. Res Involv Engagem. 2015;1:6.","journal-title":"Res Involv Engagem"},{"key":"791_CR24","doi-asserted-by":"publisher","first-page":"904291","DOI":"10.3389\/fpubh.2022.904291","volume":"10","author":"D Fortin","year":"2022","unstructured":"Fortin D, Marcellin F, Carrieri P, Mancini J, Barr\u00e9 T. Medical cannabis: toward a new policy and health model for an ancient medicine. Front Public Health. 2022;10:904291.","journal-title":"Front Public Health"},{"issue":"1","key":"791_CR25","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1111\/inm.70009","volume":"34","author":"M Goodhew","year":"2025","unstructured":"Goodhew M, Matiuk S, Axisa C, Gough C, River J. Transforming alcohol and other drug education through Co-Design. Int J Ment Health Nurs. 2025;34(1):e70009.","journal-title":"Int J Ment Health Nurs"}],"container-title":["Research Involvement and Engagement"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-025-00791-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40900-025-00791-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-025-00791-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:26:42Z","timestamp":1761316002000},"score":1,"resource":{"primary":{"URL":"https:\/\/researchinvolvement.biomedcentral.com\/articles\/10.1186\/s40900-025-00791-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1186\/s40900-025-00791-3","relation":{},"ISSN":["2056-7529"],"issn-type":[{"type":"electronic","value":"2056-7529"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The cantonal ethics committee (KEK) declared itself \u201cnot responsible\u201d for the present project [Req-2021-00609, 20th of June 2021]. This meant that the KEK waived approval of a formal study protocol for the work with the advisory group. We followed standards in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}